Sonoma Pharmaceuticals(DE:O8Z)
€2.690.00 (0.00%)
DE:O8Z
Sonoma Pharmaceuticals financials statements
€2.69
At close:0.00 (0.00%)
Sonoma Pharmaceuticals (O8Z) Income Statement
1 Followers
Sonoma Pharmaceuticals Income Statement
Last quarter (Q2 2027), Sonoma Pharmaceuticals's total revenue was $7.17M, an increase of 28.02% from the same quarter last year. In Q2, Sonoma Pharmaceuticals's net income was $-66.00K. See Sonoma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 19.53M | $ 14.29M | $ 12.73M | $ 13.27M | $ 12.63M | |
| $ 7.42M | $ 5.46M | $ 4.75M | $ 4.48M | $ 3.99M | |
| $ 9.88M | $ 9.18M | $ 9.45M | $ 9.05M | $ 9.88M | |
| Depreciation and Amortization | $ 139.00K | $ 138.00K | $ 176.00K | $ 125.00K | $ 186.00K |
| $ -2.32M | $ -2.77M | $ -4.86M | $ -5.06M | $ -5.22M | |
| $ -2.46M | $ -3.71M | $ -4.70M | $ -4.57M | $ -5.89M | |
| $ -958.00K | $ 803.00K | $ -330.00K | $ -614.00K | $ 469.00K | |
| $ -3.42M | $ -2.91M | $ -5.03M | $ -5.18M | $ -5.42M | |
| $ -3.17M | $ -3.46M | $ -4.83M | $ -5.15M | $ -5.09M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.89 | $ -2.79 | $ -5.32 | $ -15.18 | $ -19.17 |
| Diluted EPS | $ -1.89 | $ -2.79 | $ -5.32 | $ -15.18 | $ -19.17 |
| Weighted Average Shares Outstanding | 1.68M | 1.24M | 909.00K | 339.40K | 265.30K |
| Weighted Average Shares Outstanding (Diluted) | 1.68M | 1.24M | 909.00K | 339.40K | 265.30K |
Currency in USD

